Len Blavatnik, 10% Owner at Neon Therapeutics, Inc. (NTGN), sold 177,728 shares at $2.22 ($397K) on 2020-03-20, disclosed to the SEC on 2020-03-23.
Open-market sale of $397k NTGN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.51 | 9,050 | $23K | 5.7% |
| 2 | $2.22 | 84,339 | $187K | 47.1% |
| 3 | $2.22 | 84,339 | $187K | 47.1% |
| Total | $2.23 avg | 177,728 | $397K | 100% |
| Filing → |
| LYB | SELL | 2022-12-05 | $242.4M | — | Filing → |
| VRNA | BUY | 2022-08-17 | $6.3M | — | Filing → |
| DAWN | BUY | 2022-06-21 | $18.0M | — | Filing → |